位置:首页 > 蛋白库 > GDIR1_MOUSE
GDIR1_MOUSE
ID   GDIR1_MOUSE             Reviewed;         204 AA.
AC   Q99PT1; Q5M9P6; Q8BPI0; Q99KC4;
DT   11-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   03-AUG-2022, entry version 166.
DE   RecName: Full=Rho GDP-dissociation inhibitor 1;
DE            Short=Rho GDI 1;
DE   AltName: Full=GDI-1;
DE   AltName: Full=Rho-GDI alpha;
GN   Name=Arhgdia; Synonyms=C87222, Gdi1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Minamitani T., Matsumoto K.;
RT   "Mouse cDNA sequence for RhoGDI-1.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Pituitary, and Spleen;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 34-49; 59-98 AND 153-167, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Hippocampus;
RA   Lubec G., Klug S., Yang J.W., Zigmond M.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [7]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND TISSUE SPECIFICITY.
RX   PubMed=19029984; DOI=10.1038/nm.1879;
RA   Shibata S., Nagase M., Yoshida S., Kawarazaki W., Kurihara H., Tanaka H.,
RA   Miyoshi J., Takai Y., Fujita T.;
RT   "Modification of mineralocorticoid receptor function by Rac1 GTPase:
RT   implication in proteinuric kidney disease.";
RL   Nat. Med. 14:1370-1376(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   INTERACTION WITH PLXNB3.
RX   PubMed=20696765; DOI=10.1074/jbc.m110.120451;
RA   Li X., Lee A.Y.;
RT   "Semaphorin 5A and plexin-B3 inhibit human glioma cell motility through
RT   RhoGDIalpha-mediated inactivation of Rac1 GTPase.";
RL   J. Biol. Chem. 285:32436-32445(2010).
RN   [10]
RP   FUNCTION, INTERACTION WITH RHOA; RAC1 AND CDC42, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-185.
RX   PubMed=23434736; DOI=10.1136/jmedgenet-2012-101442;
RA   Gupta I.R., Baldwin C., Auguste D., Ha K.C., El Andalousi J.,
RA   Fahiminiya S., Bitzan M., Bernard C., Akbari M.R., Narod S.A.,
RA   Rosenblatt D.S., Majewski J., Takano T.;
RT   "ARHGDIA: a novel gene implicated in nephrotic syndrome.";
RL   J. Med. Genet. 50:330-338(2013).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-43 AND LYS-141, SUCCINYLATION
RP   [LARGE SCALE ANALYSIS] AT LYS-141, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 2-204 IN COMPLEX WITH PRENYLATED
RP   RHOA, FUNCTION, AND SUBUNIT.
RX   PubMed=22628549; DOI=10.1074/jbc.m112.371294;
RA   Tnimov Z., Guo Z., Gambin Y., Nguyen U.T., Wu Y.W., Abankwa D., Stigter A.,
RA   Collins B.M., Waldmann H., Goody R.S., Alexandrov K.;
RT   "Quantitative analysis of prenylated RhoA interaction with its chaperone,
RT   RhoGDI.";
RL   J. Biol. Chem. 287:26549-26562(2012).
CC   -!- FUNCTION: Controls Rho proteins homeostasis. Regulates the GDP/GTP
CC       exchange reaction of the Rho proteins by inhibiting the dissociation of
CC       GDP from them, and the subsequent binding of GTP to them. Retains Rho
CC       proteins such as CDC42, RAC1 and RHOA in an inactive cytosolic pool,
CC       regulating their stability and protecting them from degradation.
CC       Actively involved in the recycling and distribution of activated Rho
CC       GTPases in the cell, mediates extraction from membranes of both
CC       inactive and activated molecules due its exceptionally high affinity
CC       for prenylated forms. Through the modulation of Rho proteins, may play
CC       a role in cell motility regulation. In glioma cells, inhibits cell
CC       migration and invasion by mediating the signals of SEMA5A and PLXNB3
CC       that lead to inactivation of RAC1. {ECO:0000269|PubMed:19029984,
CC       ECO:0000269|PubMed:22628549, ECO:0000269|PubMed:23434736}.
CC   -!- SUBUNIT: Monomer (PubMed:22628549). Interacts with FER (By similarity).
CC       Interacts with PLXNB3 (PubMed:20696765). Forms a heterodimer with RAC1
CC       (PubMed:23434736). Interacts with RHOA, the affinity is increased by
CC       three orders of magnitude when RHOA is prenylated (PubMed:23434736).
CC       Interacts with PSMD10; the interaction increases ARHGDIA association
CC       with RHOA, leading to ARHGDIA-mediated inactivation of RHOA and ROCK
CC       and prolonged AKT activation (By similarity). Interacts with KANK2; the
CC       interaction is direct and may regulate the interaction of ARHGDIA with
CC       RHOA, RAC1 and CDC42 (By similarity). Interacts with RHOC (By
CC       similarity). Interacts with CDC42 (PubMed:23434736). Interacts with
CC       NGFR (via death domain); NGFR binding decreases the affinity for RHOA
CC       (By similarity). {ECO:0000250|UniProtKB:P52565,
CC       ECO:0000269|PubMed:20696765, ECO:0000269|PubMed:22628549,
CC       ECO:0000269|PubMed:23434736}.
CC   -!- INTERACTION:
CC       Q99PT1; P60764: Rac3; NbExp=3; IntAct=EBI-494354, EBI-644949;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23434736}.
CC   -!- TISSUE SPECIFICITY: In kidney glomerulus, expressed in podocytes and
CC       mesangial cells. {ECO:0000269|PubMed:19029984,
CC       ECO:0000269|PubMed:23434736}.
CC   -!- DISRUPTION PHENOTYPE: From 1 week to 12 weeks of age, progressive
CC       deterioration from mild to massive albuminuria as consequence of renal
CC       abnormalities. In kidney, severe podocyte damage, glomerular lesions
CC       with focal and segmental sclerosis, along with prominent intratubular
CC       casts and luminal dilatation. Tubular epithelial cells show
CC       degenerative changes with basement membrane thickening. Increase of
CC       apoptotic cells in kidney glomeruli and tubulointerstitium.
CC       {ECO:0000269|PubMed:19029984}.
CC   -!- SIMILARITY: Belongs to the Rho GDI family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB055070; BAB21527.1; -; mRNA.
DR   EMBL; AK075656; BAC35881.1; -; mRNA.
DR   EMBL; AK077343; BAC36761.1; -; mRNA.
DR   EMBL; AK143516; BAE25410.1; -; mRNA.
DR   EMBL; AK156819; BAE33865.1; -; mRNA.
DR   EMBL; AK165241; BAE38098.1; -; mRNA.
DR   EMBL; AK170553; BAE41876.1; -; mRNA.
DR   EMBL; AK170718; BAE41976.1; -; mRNA.
DR   EMBL; AK172140; BAE42844.1; -; mRNA.
DR   EMBL; AL663030; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004732; AAH04732.1; -; mRNA.
DR   EMBL; BC086755; AAH86755.1; -; mRNA.
DR   CCDS; CCDS25743.1; -.
DR   RefSeq; NP_598557.3; NM_133796.7.
DR   RefSeq; XP_006532612.1; XM_006532549.3.
DR   PDB; 4F38; X-ray; 2.80 A; B=2-204.
DR   PDBsum; 4F38; -.
DR   AlphaFoldDB; Q99PT1; -.
DR   SMR; Q99PT1; -.
DR   BioGRID; 228703; 18.
DR   IntAct; Q99PT1; 3.
DR   MINT; Q99PT1; -.
DR   STRING; 10090.ENSMUSP00000063714; -.
DR   iPTMnet; Q99PT1; -.
DR   PhosphoSitePlus; Q99PT1; -.
DR   SwissPalm; Q99PT1; -.
DR   REPRODUCTION-2DPAGE; IPI00322312; -.
DR   REPRODUCTION-2DPAGE; Q99PT1; -.
DR   UCD-2DPAGE; Q99PT1; -.
DR   EPD; Q99PT1; -.
DR   jPOST; Q99PT1; -.
DR   MaxQB; Q99PT1; -.
DR   PaxDb; Q99PT1; -.
DR   PeptideAtlas; Q99PT1; -.
DR   PRIDE; Q99PT1; -.
DR   ProteomicsDB; 267790; -.
DR   TopDownProteomics; Q99PT1; -.
DR   Antibodypedia; 3880; 580 antibodies from 39 providers.
DR   DNASU; 192662; -.
DR   Ensembl; ENSMUST00000067936; ENSMUSP00000063714; ENSMUSG00000025132.
DR   Ensembl; ENSMUST00000106197; ENSMUSP00000101803; ENSMUSG00000025132.
DR   GeneID; 192662; -.
DR   KEGG; mmu:192662; -.
DR   UCSC; uc007mtj.1; mouse.
DR   CTD; 396; -.
DR   MGI; MGI:2178103; Arhgdia.
DR   VEuPathDB; HostDB:ENSMUSG00000025132; -.
DR   eggNOG; KOG3205; Eukaryota.
DR   GeneTree; ENSGT00390000006233; -.
DR   HOGENOM; CLU_076228_1_1_1; -.
DR   InParanoid; Q99PT1; -.
DR   OMA; DDDKRCH; -.
DR   OrthoDB; 1265661at2759; -.
DR   PhylomeDB; Q99PT1; -.
DR   TreeFam; TF105387; -.
DR   Reactome; R-MMU-193634; Axonal growth inhibition (RHOA activation).
DR   Reactome; R-MMU-209563; Axonal growth stimulation.
DR   Reactome; R-MMU-8980692; RHOA GTPase cycle.
DR   Reactome; R-MMU-9013106; RHOC GTPase cycle.
DR   Reactome; R-MMU-9013148; CDC42 GTPase cycle.
DR   Reactome; R-MMU-9013149; RAC1 GTPase cycle.
DR   Reactome; R-MMU-9013404; RAC2 GTPase cycle.
DR   Reactome; R-MMU-9013407; RHOH GTPase cycle.
DR   Reactome; R-MMU-9013408; RHOG GTPase cycle.
DR   BioGRID-ORCS; 192662; 2 hits in 74 CRISPR screens.
DR   ChiTaRS; Arhgdia; mouse.
DR   PRO; PR:Q99PT1; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q99PT1; protein.
DR   Bgee; ENSMUSG00000025132; Expressed in embryonic post-anal tail and 271 other tissues.
DR   Genevisible; Q99PT1; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005615; C:extracellular space; ISO:MGI.
DR   GO; GO:0001772; C:immunological synapse; IDA:MGI.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISO:MGI.
DR   GO; GO:0005504; F:fatty acid binding; ISO:MGI.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0051879; F:Hsp90 protein binding; ISO:MGI.
DR   GO; GO:0019901; F:protein kinase binding; ISO:MGI.
DR   GO; GO:0005094; F:Rho GDP-dissociation inhibitor activity; IDA:MGI.
DR   GO; GO:0031267; F:small GTPase binding; ISO:MGI.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISO:MGI.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:MGI.
DR   GO; GO:2000249; P:regulation of actin cytoskeleton reorganization; ISO:MGI.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:MGI.
DR   GO; GO:0032880; P:regulation of protein localization; IDA:MGI.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; ISO:MGI.
DR   GO; GO:0007266; P:Rho protein signal transduction; IDA:MGI.
DR   GO; GO:0071526; P:semaphorin-plexin signaling pathway; IMP:UniProtKB.
DR   Gene3D; 2.70.50.30; -; 1.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR000406; Rho_GDI.
DR   InterPro; IPR024792; RhoGDI_dom_sf.
DR   PANTHER; PTHR10980; PTHR10980; 1.
DR   Pfam; PF02115; Rho_GDI; 1.
DR   PRINTS; PR00492; RHOGDI.
DR   SUPFAM; SSF81296; SSF81296; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   GTPase activation; Isopeptide bond; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P52565"
FT   CHAIN           2..204
FT                   /note="Rho GDP-dissociation inhibitor 1"
FT                   /id="PRO_0000219014"
FT   REGION          1..36
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P52565"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         43
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P52565"
FT   MOD_RES         105
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P52565"
FT   MOD_RES         127
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P52565"
FT   MOD_RES         141
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         141
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         178
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P52565"
FT   CROSSLNK        138
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52565"
FT   CROSSLNK        138
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52565"
FT   CROSSLNK        141
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52565"
FT   CROSSLNK        141
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52565"
FT   MUTAGEN         185
FT                   /note="Missing: Loss of interaction with CDC42, RHOA and
FT                   RAC1."
FT                   /evidence="ECO:0000269|PubMed:23434736"
FT   CONFLICT        55
FT                   /note="L -> P (in Ref. 4; AAH04732)"
FT                   /evidence="ECO:0000305"
FT   HELIX           11..14
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   HELIX           35..40
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   TURN            41..44
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   HELIX           46..56
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   STRAND          69..78
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   STRAND          86..92
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   HELIX           94..99
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   STRAND          101..105
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   STRAND          109..118
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   STRAND          123..134
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   STRAND          137..149
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   STRAND          152..156
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   TURN            169..171
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   STRAND          173..182
FT                   /evidence="ECO:0007829|PDB:4F38"
FT   STRAND          190..201
FT                   /evidence="ECO:0007829|PDB:4F38"
SQ   SEQUENCE   204 AA;  23407 MW;  8ACE6F4456D842D8 CRC64;
     MAEQEPTAEQ LAQIAAENEE DEHSVNYKPP AQKSIQEIQE LDKDDESLRK YKEALLGRVA
     VSADPNVPNV IVTRLTLVCS TAPGPLELDL TGDLESFKKQ SFVLKEGVEY RIKISFRVNR
     EIVSGMKYIQ HTYRKGVKID KTDYMVGSYG PRAEEYEFLT PMEEAPKGML ARGSYNIKSR
     FTDDDKTDHL SWEWNLTIKK EWKD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024